Clinical Trials Logo

Surveillance Colonoscopy clinical trials

View clinical trials related to Surveillance Colonoscopy.

Filter by:
  • None
  • Page 1

NCT ID: NCT04640792 Completed - Clinical trials for Screening Colonoscopy

A Study to Evaluate the Safety and Efficacy of the Use of ME-APDS During Colonoscopy

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

ME-APDS is a device (software-based with hardware) developed by Magentiq Eye LTD and intended to support the decision of the endoscopist on polyps which appear in the colonoscopy video during the colonoscopy procedure. This randomized two arm colonoscopy trial will mainly compare APC and APE between Magentiq Eye Assisted Colonoscopy (MEAC) and Conventional Colonoscopy (CC) in patients referred for either screening or surveillance colonoscopies.

NCT ID: NCT04034563 Recruiting - Clinical trials for Surveillance Colonoscopy

Post-polypectomy Surveillance Interval In High-risk Subjects After Screening Colonoscopy

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

With many countries initiating population colorectal cancer (CRC) screening, including Hong Kong, more robust guidance for surveillance interval is required to maximize subject's benefit with optimal use of resources. Surveillance interval after removal of advanced adenoma at screening colonoscopy remains unclear. The current recommendation of 3-year is based on data collected before widespread implementation of population screening programs and quality metrics in colonoscopy. These high-risk subjects are those most likely to benefit from surveillance and represent the majority of the demand in surveillance colonoscopies.

NCT ID: NCT01838408 Completed - Colonoscopy Clinical Trials

Evaluation of Proposed EZ2go Complete Bowel Cleansing System

Start date: April 2013
Phase: N/A
Study type: Interventional

This study aims to provide safety and efficacy data comparable to available over-the-counter bowel preparations prior to colonoscopy. While there are many bowel preparations available, most of them remain expensive and require prescription from a health provider. The investigators believe EZ2go Complete will provide a non-inferior colon cleansing in a more accessible way (over-the-counter). To accomplish this goal, the investigators decided to evaluate the proposed EZ2go combination versus currently available over-the-counter bowel preparations. The investigators believe the EZ2go kit will not be inferior to current FDA approved over-the-counter bowel preparations.